Suicide gene therapy for intractable gastrointestinal cancer with tumor specific promoters

具有肿瘤特异性启动子的自杀基因治疗顽固性胃肠癌

基本信息

  • 批准号:
    13670580
  • 负责人:
  • 金额:
    $ 2.62万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 财政年份:
    2001
  • 资助国家:
    日本
  • 起止时间:
    2001 至 2002
  • 项目状态:
    已结题

项目摘要

We examined the transcriptional regulatory regions of the midkine gene, which is expressed in a variety of tumors but scarcely in normal cells, with luciferase reporter assays. We demonstrated that the most potent transcriptional activity was obtained with the 2335-bp upstream region tested in hepatocellular carcinoma and with the 609-bp region in pancreatic tumors. The 1041- and the 335-bp but not the 70-bp region contained cis-acting elements for transcriptional activation in both types of tumor cells. Transfection of the herpes simplex virus-thymidine kinase (HSV-TK) gene fused with the midkine regulatory region in tumor cells increased their susceptibility to a prodrug ganciclovir. The regulatory regions of the c-erbB-2 gene, which is highly expressed in breast and gastric cancer, were also analyzed with the same reporter assays. We showed that the activity of the 251-bp region was the strongest in tumors among other genomic fragments deleted from 5'-side. Tumor cells transfected with the 251-bp region linked with the HSV-TK gene was more sensitive to ganciclovir in vitro and in vivo than parent cells. We also investigated the transcriptional control regions of the survivin gene, which is highly expressed in the G2/M phase. Deletion of the regulatory regions from the 5'-side showed that the 500-bp region was responsible for the preferential expression in tumor cells but not in normal cells.
我们通过荧光素酶报告基因检测检查了中期因子基因的转录调控区,该基因在多种肿瘤中表达,但在正常细胞中几乎不表达。我们证明,在肝细胞癌中测试的 2335 bp 上游区域和在胰腺肿瘤中测试的 609 bp 区域获得了最有效的转录活性。 1041 bp 和 335 bp 区域包含用于两种类型肿瘤细胞转录激活的顺式作用元件,但 70 bp 区域不包含。与肿瘤细胞中的中期因子调节区融合的单纯疱疹病毒胸苷激酶(HSV-TK)基因的转染增加了它们对前药更昔洛韦的敏感性。 c-erbB-2 基因的调控区域在乳腺癌和胃癌中高度表达,也使用相同的报告基因检测进行了分析。我们发现,在肿瘤中 5' 侧删除的其他基因组片段中,251 bp 区域的活性最强。转染有HSV-TK基因的251bp区域的肿瘤细胞在体外和体内比亲代细胞对更昔洛韦更敏感。我们还研究了生存素基因的转录控制区,该基因在 G2/M 期高表达。删除 5' 侧的调控区表明 500 bp 区域负责在肿瘤细胞中优先表达,但在正常细胞中则不然。

项目成果

期刊论文数量(34)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Maeda, T., O-Wang, J., Matsubara, H., Asano, T., Ochiai, T., Sakiyama, S. and Tagawa, M.: "A minimum c-erbB-2 promoter-mediated expression of herpes simplex virus thymidine kinase gene confers selective cytotoxicity of human breast cancer cells to gancicl
Maeda, T.、O-Wang, J.、Matsubara, H.、Asano, T.、Ochiai, T.、Sakiyama, S. 和 Takawa, M.:“最小 c-erbB-2 启动子介导的表达
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Miyauchi, M., Yoshida, Y., Tada, Y., Narita, M., Maeda, T., Bahar, R., Kadomatsu, K., Muramatsu, T., Matsubara, S., Nakagawara, A., Sakiyama, S. and Tagawa, M.: "Expression of herpes simplex virus-thymidine kinase gene controlled by a promoter region of t
宫内,M.,吉田,Y.,多田,Y.,成田,M.,前田,T.,巴哈,R.,门松,K.,村松,T.,松原,S.,中川原,A.,
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Maeda T, Tagawa M, et al.: "A minimum c-erbB-2 promoter-mediated expression of herpes simplex virus thymidine kinase gene confers selective cytotoxicity of human breast cancer cells to ganciclovir"Cancer Gene Ther.. 8. 890-896 (2001)
Maeda T、Takawa M 等人:“单纯疱疹病毒胸苷激酶基因的最小 c-erbB-2 启动子介导的表达赋予人乳腺癌细胞对更昔洛韦的选择性细胞毒性”癌症基因治疗.. 8. 890-896
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Kawamura, K., Bahar, R., Natsume, W., Sakiyama, S. and Tagawa, T.: "Secretion of interleukin-10 from murine colon carcinoma cells suppresses systemic anti-tumor immuinuty and impairs protective immunity induced against the tumors"Cancer Gene Ther.. 9. 109
Kawamura, K.、Bahar, R.、Natsume, W.、Sakiyama, S. 和 Takawa, T.:“小鼠结肠癌细胞分泌白细胞介素 10 会抑制全身抗肿瘤免疫并损害针对肿瘤诱导的保护性免疫
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Kawamura K, Tagawa T, et al.: "Secretion of interleukin-10 from murine colon carcinoma cells suppresses systemic anti-tumor immunity and impairs protective immunity induced against the tumors"Cancer Gene Ther.. 9. 109-115 (2002)
Kawamura K、Takawa T 等人:“小鼠结肠癌细胞分泌白细胞介素 10 会抑制全身抗肿瘤免疫并削弱针对肿瘤诱导的保护性免疫”Cancer Gene Ther.. 9. 109-115 (2002)
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

KAWAMURA Kiyoko其他文献

KAWAMURA Kiyoko的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('KAWAMURA Kiyoko', 18)}}的其他基金

Anti-tumor effects for solid tumors in digestive tracts were produced by a chimeric type of oncolytic adenoviruses and the carrier cells
嵌合型溶瘤腺病毒和载体细胞对消化道实体瘤产生抗肿瘤作用
  • 批准号:
    21590879
  • 财政年份:
    2009
  • 资助金额:
    $ 2.62万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Therapeutic strategies with chimeric oncolytic adenoviruses and a cell-mediated delivery system for gastrointestinal solid tumors
嵌合溶瘤腺病毒和细胞介导的递送系统治疗胃肠道实体瘤的治疗策略
  • 批准号:
    19590798
  • 财政年份:
    2007
  • 资助金额:
    $ 2.62万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Gene therapy for gastrointestinal tumors with adenovirus in which the fiber-knob region was replaced
用腺病毒治疗胃肠道肿瘤,其中纤维旋钮区域被替换
  • 批准号:
    17590692
  • 财政年份:
    2005
  • 资助金额:
    $ 2.62万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Gene therapy for intractable gastrointestinal tumors with tumor promoter-mediated oncolyitc adenoviruses
肿瘤启动子介导的溶瘤腺病毒对难治性胃肠道肿瘤的基因治疗
  • 批准号:
    15590706
  • 财政年份:
    2003
  • 资助金额:
    $ 2.62万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Therapeutic effects of cytokine gene therapy and suicide gene therapy for gastrointestinal tumors
细胞因子基因治疗和自杀基因治疗对胃肠道肿瘤的治疗效果
  • 批准号:
    11670556
  • 财政年份:
    1999
  • 资助金额:
    $ 2.62万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)

相似国自然基金

芳香类中药渗透促进剂“佐使”抗肿瘤树突状细胞疫苗淋巴迁移的物质基础及趋向机制研究
  • 批准号:
    81973494
  • 批准年份:
    2019
  • 资助金额:
    55 万元
  • 项目类别:
    面上项目

相似海外基金

Designing a transcriptome-based, targeted theranostic platform for prostate cancer
设计基于转录组的前列腺癌靶向治疗平台
  • 批准号:
    10553662
  • 财政年份:
    2020
  • 资助金额:
    $ 2.62万
  • 项目类别:
microRNA therapies for advanced brain tumors
晚期脑肿瘤的 microRNA 疗法
  • 批准号:
    10547976
  • 财政年份:
    2020
  • 资助金额:
    $ 2.62万
  • 项目类别:
Cancer-specific nanoparticle-mediated gene therapy to treat hepatocellular carcinoma
癌症特异性纳米颗粒介导的基因疗法治疗肝细胞癌
  • 批准号:
    9094869
  • 财政年份:
    2016
  • 资助金额:
    $ 2.62万
  • 项目类别:
Genetic correction of human beta-thalassemic induced pluripotent stem cells
人β地中海贫血诱导多能干细胞的遗传校正
  • 批准号:
    8955926
  • 财政年份:
    2012
  • 资助金额:
    $ 2.62万
  • 项目类别:
Genotypic Interactions in Brain Cancer Heterogeneity
脑癌异质性中的基因型相互作用
  • 批准号:
    9899325
  • 财政年份:
    2012
  • 资助金额:
    $ 2.62万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了